252 related articles for article (PubMed ID: 26609190)
21. Radiology in the diagnosis and staging of renal cell carcinoma.
Zagoria RJ; Dyer RB; Wolfman NT; Hinn GC; Chen YM
Crit Rev Diagn Imaging; 1990; 31(1):81-115. PubMed ID: 2288659
[TBL] [Abstract][Full Text] [Related]
22. [Radiologic staging of renal cell carcinoma].
Szolar DH; Zebedin D; Unger B; Pummer K; Ranner G
Radiologe; 1999 Jul; 39(7):584-90. PubMed ID: 10472087
[TBL] [Abstract][Full Text] [Related]
23. Imaging renal cell carcinoma with ultrasonography, CT and MRI.
Leveridge MJ; Bostrom PJ; Koulouris G; Finelli A; Lawrentschuk N
Nat Rev Urol; 2010 Jun; 7(6):311-25. PubMed ID: 20479778
[TBL] [Abstract][Full Text] [Related]
24. Contemporary imaging modalities for the surveillance of patients with renal cell carcinoma.
Tollefson MK; Takahashi N; Leibovich BC
Curr Urol Rep; 2007 Jan; 8(1):38-43. PubMed ID: 17239315
[TBL] [Abstract][Full Text] [Related]
25. Hereditary Leiomyomatosis and Renal Cell Cancer: Clinical, Molecular, and Screening Features in a Cohort of 185 Affected Individuals.
Forde C; Lim DHK; Alwan Y; Burghel G; Butland L; Cleaver R; Dixit A; Evans DG; Hanson H; Lalloo F; Oliveira P; Vialard L; Wallis Y; Maher ER; Woodward ER
Eur Urol Oncol; 2020 Dec; 3(6):764-772. PubMed ID: 31831373
[TBL] [Abstract][Full Text] [Related]
26. Imaging after local tumor therapies: kidney and liver.
Kielar AZ; Hibbert RM; Maturen KE
Semin Roentgenol; 2013 Jul; 48(3):273-84. PubMed ID: 23796378
[No Abstract] [Full Text] [Related]
27. Prognostic factors in renal cell carcinoma.
Shuch BM; Lam JS; Belldegrun AS; Figlin RA
Semin Oncol; 2006 Oct; 33(5):563-75. PubMed ID: 17045085
[TBL] [Abstract][Full Text] [Related]
28. Role of MRI in indeterminate renal mass: diagnostic accuracy and impact on clinical decision making.
Kwon T; Jeong IG; Yoo S; Lee J; Hong S; You D; Hong JH; Ahn H; Kim CS
Int Urol Nephrol; 2015 Apr; 47(4):585-93. PubMed ID: 25681121
[TBL] [Abstract][Full Text] [Related]
29. Predictive Value of Chemical-Shift MRI in Distinguishing Clear Cell Renal Cell Carcinoma From Non-Clear Cell Renal Cell Carcinoma and Minimal-Fat Angiomyolipoma.
Jhaveri KS; Elmi A; Hosseini-Nik H; Hedgire S; Evans A; Jewett M; Harisinghani M
AJR Am J Roentgenol; 2015 Jul; 205(1):W79-86. PubMed ID: 26102422
[TBL] [Abstract][Full Text] [Related]
30. Renal cell carcinoma: diagnosis, staging, and surveillance.
Ng CS; Wood CG; Silverman PM; Tannir NM; Tamboli P; Sandler CM
AJR Am J Roentgenol; 2008 Oct; 191(4):1220-32. PubMed ID: 18806169
[TBL] [Abstract][Full Text] [Related]
31. Renal cell carcinoma: recent advances in genetics and imaging.
Choudhary S; Sudarshan S; Choyke PL; Prasad SR
Semin Ultrasound CT MR; 2009 Aug; 30(4):315-25. PubMed ID: 19711643
[TBL] [Abstract][Full Text] [Related]
32. Three-dimensional gadolinium-enhanced magnetic resonance breath-hold FLASH imaging in the diagnosis and staging of renal cell carcinoma.
Tuite DJ; Geoghegan T; McCauley G; Govender P; Browne RJ; Torreggiani WC
Clin Radiol; 2006 Jan; 61(1):23-30. PubMed ID: 16356813
[TBL] [Abstract][Full Text] [Related]
33. MR evaluation of solid renal masses.
Ho VB; Choyke PL
Magn Reson Imaging Clin N Am; 2004 Aug; 12(3):413-27, v. PubMed ID: 15271363
[TBL] [Abstract][Full Text] [Related]
34. Arterial spin-labeling MR imaging of renal masses: correlation with histopathologic findings.
Lanzman RS; Robson PM; Sun MR; Patel AD; Mentore K; Wagner AA; Genega EM; Rofsky NM; Alsop DC; Pedrosa I
Radiology; 2012 Dec; 265(3):799-808. PubMed ID: 23047841
[TBL] [Abstract][Full Text] [Related]
35. Measuring perfusion and permeability in renal cell carcinoma with dynamic contrast-enhanced MRI: a pilot study.
Notohamiprodjo M; Sourbron S; Staehler M; Michaely HJ; Attenberger UI; Schmidt GP; Boehm H; Horng A; Glaser C; Stief C; Reiser MF; Herrmann KA
J Magn Reson Imaging; 2010 Feb; 31(2):490-501. PubMed ID: 20099364
[TBL] [Abstract][Full Text] [Related]
36. Multiparametric MRI of solid renal masses: pearls and pitfalls.
Ramamurthy NK; Moosavi B; McInnes MD; Flood TA; Schieda N
Clin Radiol; 2015 Mar; 70(3):304-16. PubMed ID: 25472466
[TBL] [Abstract][Full Text] [Related]
37. Genomics and proteomics in renal cell carcinoma: diagnosis, prognosis, and treatment selection.
Jones J; Pantuck AJ
Curr Urol Rep; 2008 Jan; 9(1):9-14. PubMed ID: 18366968
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of treatment response in patients with metastatic renal cell carcinoma: role of state-of-the-art cross-sectional imaging.
Katabathina VS; Lassau N; Pedrosa I; Ng CS; Prasad SR
Curr Urol Rep; 2012 Feb; 13(1):70-81. PubMed ID: 22143974
[TBL] [Abstract][Full Text] [Related]
39. Gene expression profiling of renal cell carcinoma.
Tan MH; Rogers CG; Cooper JT; Ditlev JA; Maatman TJ; Yang X; Furge KA; Teh BT
Clin Cancer Res; 2004 Sep; 10(18 Pt 2):6315S-21S. PubMed ID: 15448024
[TBL] [Abstract][Full Text] [Related]
40. EAU guidelines on renal cell carcinoma: the 2010 update.
Ljungberg B; Cowan NC; Hanbury DC; Hora M; Kuczyk MA; Merseburger AS; Patard JJ; Mulders PF; Sinescu IC;
Eur Urol; 2010 Sep; 58(3):398-406. PubMed ID: 20633979
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
